MIM
HALO icon

Monashee Investment Management’s Halozyme HALO Stock Holding History

Monashee Investment Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-36,254
Closed -$465K – 103
2017
Q2 		$465K Buy
+36,254
New +$484K 0.2% 71

Other funds holding HALO

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Monashee Investment Management's HALO Position: Q3 2017 in Review

Monashee Investment Management sold out of Halozyme (HALO) in Q3 2017, closing a stake of 36,254 shares — an estimated $465K sold.

Monashee Investment Management first reported a position in HALO in Q2 2017 and held it in 1 quarter. The position peaked at $465K in Q2 2017. 166 funds tracked by Wall St. Rank hold HALO as of Q3 2017.

  • Monashee Investment Management reported no remaining Halozyme position as of Q3 2017 after selling out during the quarter.
  • Monashee Investment Management sold 36,254 Halozyme shares in Q3 2017, an estimated $465K.
  • Monashee Investment Management first reported a position in Halozyme in Q2 2017 and held it in 1 quarter.
  • Monashee Investment Management's Halozyme position peaked at $465K in Q2 2017.
  • 166 funds tracked by Wall St. Rank held Halozyme as of Q3 2017.

Based on Monashee Investment Management's 13F filing for Q3 2017, filed 13 Nov 2017.